A Comprehensive Model for Diagnosis of Primary Breast Lymphoma Differentiated From Breast Cancer and Prognosis Evaluation of Surgical Treatment

Background The objective of this work was to discriminate between primary breast lymphoma (PBL) and breast cancer by systematically analyzing clinical characteristics, laboratory examination results, ultrasound features, and mammography findings to establish a diagnostic model for PBL and to analyze the influence of surgical treatment on the prognosis of PBL patients. Method We analyzed 20 PBL and 70 breast cancer patients treated during the same period by comparing several characteristics: clinical features, such as age, tumor position, and breast complaints; laboratory examination findings, such as the lactate dehydrogenase (LDH) level, and imaging features such as the maximum diameter, shape, margins, aspect ratio, and calcification of the mass and axillary lymph node involvement. A diagnostic model was then developed using logistic regression analysis. The impact of surgery on the prognosis of PBL patients was assessed through Kaplan–Meier survival analysis. Result Breast cancer and PBL could be distinguished based on imaging features, including the maximum diameter, shape, margin, and calcification of the mass, and lymph node involvement (P < 0.05). There were no significant differences between PBL and breast cancer patients in terms of clinical features, or the LDH level. The area under the receiver operating characteristic curve was 0.821. The log-rank test showed that surgery had no significant influence on the prognosis of PBL patients. Conclusion Ultrasound and mammography are the most useful methods for detecting malignant breast tumors. Compared with breast cancer tumors, breast lymphoma tumors are larger with a more regular shape and less calcification and are often accompanied by axillary lymph node involvement. Patients with a breast malignancy should not undergo surgical excision without an accurate diagnosis.

[1]  Weili Zhao,et al.  Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B‐cell lymphoma , 2020, Clinical and translational medicine.

[2]  E. Burnside,et al.  Cancer Yield and Patterns of Follow-up for BI-RADS Category 3 after Screening Mammography Recall in the National Mammography Database. , 2020, Radiology.

[3]  Amy M. Sitapati,et al.  Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. , 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

[4]  A. Tagliafico,et al.  Primary and Secondary Breast Lymphoma: Focus on Epidemiology and Imaging Features , 2019, Pathology & Oncology Research.

[5]  V. Dialani,et al.  Primary and Secondary Breast Lymphoma: Clinical, Pathologic, and Multimodality Imaging Review. , 2019, Radiographics : a review publication of the Radiological Society of North America, Inc.

[6]  Yu Zhao,et al.  Primary breast diffuse large B‐cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failure , 2018, Cancer science.

[7]  M. Morgan,et al.  Microcalcifications in breast cancer: From pathophysiology to diagnosis and prognosis. , 2018, Biochimica et biophysica acta. Reviews on cancer.

[8]  A. Ng,et al.  Management and outcomes of women diagnosed with primary breast lymphoma: a multi-institution experience , 2018, Breast Cancer Research and Treatment.

[9]  W. Heindel,et al.  Radiological imaging characteristics of intramammary hematological malignancies: results from a german multicenter study , 2017, Scientific Reports.

[10]  M. Dryden,et al.  BI-RADS® fifth edition: A summary of changes. , 2017, Diagnostic and interventional imaging.

[11]  Brandi T. Nicholson,et al.  Extranodal Lymphoma of the Breast. , 2016, Radiologic clinics of North America.

[12]  Haydee Ojeda-Fournier,et al.  A Pictorial Review of Changes in the BI-RADS Fifth Edition. , 2016, Radiographics : a review publication of the Radiological Society of North America, Inc.

[13]  C. Mandal,et al.  A Molecular View of Pathological Microcalcification in Breast Cancer , 2016, Journal of Mammary Gland Biology and Neoplasia.

[14]  M. Lippman,et al.  A review of clinical aspects of breast cancer , 2014, International review of psychiatry.

[15]  D. Bussen,et al.  Gore BioA Fistula Plug in the treatment of high anal fistulas – initial results from a German multicenter-study , 2012, German medical science : GMS e-journal.

[16]  M. Routbort,et al.  Lymphomas Involving the Breast: A Study of 106 Cases Comparing Localized and Disseminated Neoplasms , 2008, The American journal of surgical pathology.

[17]  C. Lyou,et al.  Mammographic and sonographic findings of primary breast lymphoma. , 2007, Clinical imaging.

[18]  P. Schiano,et al.  SUMMARY OF CHANGES , 2003 .